MMMagdalena Mielczarek-Puta

Magdalena Mielczarek-Puta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Magdalena Mielczarek-Puta has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ferroptosis in orthopedic implant integration after oncologic surgery

    by Pierre-Olivier Karbonowski, Gwan Yong Lim, Karolina Lach, Michał Skrzycki, Magdalena Mielczarek-Puta

    Primary bone cancer treatment often requires large bone resections followed by reconstruction using orthopedic implants, which are usually made of titanium (Ti). In oncologic patients, the bone-implant interface (BII) microenvironment is compromised by adjuvant therapies, such as chemotherapy and radiotherapy, which impair tissue repair and disrupt redox homeostasis. Despite high biocompatibility of Ti implants, their long-term success is challenged by the continuous release of degradation products Ti4+ ions and titanium dioxide (TiO2) nanoparticles, which promote chronic inflammatory and oxidative responses at the BII. Ferroptosis, an iron-dependent cell death characterized by lipid peroxidation primarily driven by an increase in reactive oxygen species, has emerged as an important contributor to understanding peri-implant pathology. Recent studies suggest that ferroptosis is associated with impaired osseointegration by inhibiting bone formation and accelerating bone resorption, leading to uncoupled bone remodeling, periprosthetic osteolysis and aseptic loosening. Therefore, modulating ferroptosis appears to be a potential therapeutic strategy. These strategies include implant surface modification with iron chelation or antioxidant coating, as well as pharmaceutical approaches targeting redox-regulatory pathways, such as glutathione peroxidase 4 (GPX4) and nuclear factor erythroid 2-related factor 2 (Nrf2) modulators. This molecular targeting presents a promising therapeutic avenue to preserve BII and potentially improve long-term implant survival in bone cancer patients. In this mini-review, we summarized the effects of ferroptosis on orthopedic implants, highlighting the potential of ferroptotic-targeting treatment to improve long-term implant outcomes in patients undergoing oncologic reconstruction.

  • Open Access

    Mitochondrial-Targeted Triphenylphosphonium-Conjugated Ionophores with Enhanced Cytotoxicity in Cancer Cells

    by Michał Sulik, Marta Jędrzejczyk, Magdalena Mielczarek-Puta, Jakub Hoser, Piotr Bednarczyk, Marta Struga, Adam Huczyński

    Salinomycin and monensin represent a class of natural ionophore antibiotics with strong anticancer properties. In this paper we report on chemical modification of these compounds by conjugation with phosphonium cations for targeting conjugates to the mitochondria of cancer cells. Our findings indicate that this approach yields conjugates with enhanced anticancer activity and selectivity, outperforming not only the parent compounds but also the widely used chemotherapeutic agent, doxorubicin. Comprehensive biological and biophysical analyses proved that the conjugates target the mitochondria in cancer cells, with some of the derivatives additionally promoting generation of mitochondrial reactive oxygen species (mtROS). This targeted strategy holds significant promise for the development of effective mitochondrial-targeted novel anticancer agent.


  • Open Access

    Real-Time Biomarkers of Liver Graft Quality in Hypothermic Oxygenated Machine Perfusion

    by Andriy Zhylko, Marcin Morawski, Paweł Rykowski, Maciej Krasnodębski, Anya Wyporski, Jan Borkowski, Dmytro Zhylko, Konrad Kobryń, Rafał Stankiewicz, Jan Stypułkowski, et al.

    Background: Hypothermic oxygenated machine perfusion has emerged as a strategy to alleviate ischemic-reperfusion injury in liver grafts. Nevertheless, there is limited data on the effectiveness of hypothermic liver perfusion in evaluating organ quality. This study aimed to introduce a readily accessible real-time predictive biomarker measured in machine perfusate for post-transplant liver graft function. Methods: The study evaluated perfusate analytes over a 90-day postoperative period in 26 patients randomly assigned to receive a liver graft following dual hypothermic machine perfusion in a prospective randomized controlled trial. Machine perfusion was consistently conducted end-ischemically for at least 120 min, with real-time perfusate assessment at 30-min intervals. Graft functionality was assessed using established metrics, including Early Allograft Dysfunction (EAD). Results: Perfusate lactate concentration after 120 min of machine perfusion demonstrated significant predictive value for EAD (AUC ROC: 0.841, p = 0.009). Additionally, it correlated with post-transplant peak transaminase levels and extended hospital stays. Subgroup analysis revealed significantly higher lactate accumulation in livers with post-transplant EAD. Conclusions: Liver graft quality can be effectively assessed during hypothermic machine perfusion using simple perfusate lactate measurements. The reliability and accessibility of this evaluation support its potential integration into diverse transplant centers.


  • Open Access

    Routine end-ischemic hypothermic machine perfusion in liver transplantation from donors after brain death: results of 2-year follow-up of a randomized controlled trial

    by Marcin Morawski, Andriy Zhylko, Paweł Rykowski, Maciej Krasnodębski, Wacław Hołówko, Zbigniew Lewandowski, Magdalena Mielczarek-Puta, Marta Struga, Benedykt Szczepankiewicz, Barbara Górnicka, et al.

    Background: Data on routine hypothermic machine perfusion of livers procured from donors after brain death (DBD) are scarce, and the benefits of the method have only been demonstrated in extended criteria grafts. This study aimed to assess if end-ischemic dual hypothermic oxygenated machine perfusion (dHOPE) is superior to static cold storage (SCS) in preservation of livers procured from DBD donors with respect to long-term outcomes. Existing data on short-term outcomes favours dHOPE in patients receiving high-risk grafts. Methods: This prospective randomized controlled trial included 104 recipients of DBD livers randomly assigned to SCS arm (78 patients) and the dHOPE arm (26 patients). Endpoints of interest were the occurrence of biliary complications (biliary fistula, anastomotic, and nonanastomotic strictures) and overall patient and graft survival (GS) during the 2-year follow-up. Results: A total of 36 patients developed biliary complications (at least one event) – six events in dHOPE arm and 30 in SCS arm. There was no significant difference in biliary complications between groups (23.7 vs. 43.4%, P=0.11). No differences were found significant with respect to anastomotic (19.9 vs. 33.7%, P=0.20) and nonanastomotic strictures (0 vs. 11.1%, P=0.10) as well as biliary fistulas (11.7 vs. 12.2%, P=0.93). Survival analysis did not show significantly different results in the study population – overall survival: 92.3% in dHOPE and 83.9% in SCS (P=0.35), and GS: 92.3 and 81.4% (P=0.23), respectively. However, a significant difference in GS was noted in recipients of high-risk grafts – 100% in dHOPE and 73.1% in SCS, respectively (P=0.038). Conclusions: The long-term outcome data suggest that the routine use of dHOPE may be beneficial for recipients of high-risk grafts from DBD donors. The present study does not provide any evidence for the benefits of dHOPE in low-risk grafts.


  • Open Access

    Teriflunomide – The common drug with underestimated oxygen - Dependent anticancer potential

    by Dagmara Otto-Ślusarczyk, Wojciech Graboń, Magdalena Mielczarek-Puta, Alicja Chrzanowska


  • Open Access

    Design, Synthesis, and In Vitro Antiproliferative Activity of Hydantoin and Purine Derivatives with the 4-Acetylphenylpiperazinylalkyl Moiety

    by Agnieszka Zagórska, Anna Czopek, Anna Jaromin, Magdalena Mielczarek-Puta, Marta Struga, Dorota Stary, Marek Bajda

    Cancer represents one of the most serious health problems and the second leading cause of death around the world. Heterocycles, due to their prevalence in nature as well as their structural and chemical diversity, play an immensely important role in anti-cancer drug discovery. In this paper, a series of hydantoin and purine derivatives containing a 4-acetylphenylpiperazinylalkyl moiety were designed, synthesized, and biologically evaluated for their anticancer activity on selected cancer cell lines (PC3, SW480, SW620). Compound 4, a derivative of 3′,4′-dihydro-2′H-spiro[imidazolidine-4,1′-naphthalene]-2,5-dione, was the most effective against SW480, SW620, and PC3 cancer cell lines. Moreover, 4 has high tumor-targeting selectivity. Based on docking studies, it was concluded that R isomers of 3′,4′-dihydro-2′H-spiro[imidazolidine-4,1′-naphthalene]-2,5-dione could be further studied as promising scaffolds for the development of thymidine phosphorylase inhibitors.


  • Molecular mechanisms of ethanol biotransformation: enzymes of oxidative and nonoxidative metabolic pathways in human

    by Grażyna Kubiak-Tomaszewska, Piotr Tomaszewski, Jan Pachecka, Marta Struga, Wioletta Olejarz, Magdalena Mielczarek-Puta, Grażyna Nowicka

    Ethanol, as a small-molecule organic compound exhibiting both hydrophilic and lipophilic properties, quickly pass through the biological barriers. Over 95% of absorbed ethanol undergoes biotransfor...


    • 6 December 2017
      • Vol. 70  (5) , 946-952

    [Effect of antioxidants on human primary and metastatic colon cancer cells at hypoxia and normoxia].

    by Magdalena Mielczarek-Puta, Alicja Chrzanowska, Dagmara Otto-Ślusarczyk, Wojciech Graboń, Anna Barańczyk-Kuźma

    Evaluation of some antioxidants on human colon cancer cells viability and proliferation at various oxygen levels. Human primary (SW480) and metastatic (SW620) colon cancer cells were cultured at hypoxia (1% oxygen), tissues (10% oxygen) and atmospheric (21% oxygen) normoxia with quercetin, epigallocatechin gallate, lipoic acid, hydroxycitric acid, their mixture, and without studied compounds (control). Antioxidants were used at physiological concentrations. The cell viability was determined by trypan blue dye exclusion and proliferation by MTT assay. The viability of each line ranged from 80% to 97%, and it was independent on the compound and oxygen availability. At hypoxia the cell count of both lines was lower than for the controls in the presence of each studied compound. At tissue normoxia the cell count of primary cancer cells was decreased only with epigallocatechin gallate, whereas metastatic cells were sensitive for each antioxidant. Our results indicated, that the studied antioxidants were not cytotoxic at physiological levels for both pirmary and metastatic colon cancer. Their cytostatic effect depend on the type of cell, oxygen availability and antioxidant concentration.


  • Effect of different concentrations of oxygen on expression of sigma 1 receptor and superoxide dismutases in human colon adenocarcinoma cell lines

    by Michał Skrzycki, Hanna Czeczot, Magdalena Mielczarek-Puta, Dagmara Otto-Ślusarczyk, Wojciech Graboń

    Context: Tumor cells due to distance from capillary vessels exist in different oxygenation conditions (anoxia, hypoxia, normoxia). Changes in cell oxygenation lead to reactive oxygen species production and oxidative stress. Sigma 1 receptor (Sig1R) is postulated to be stress responding agent and superoxide dismutases (SOD1 and SOD2) are key antioxidant enzymes. It is possible that they participate in tumor cells adaptation to different concentrations of oxygen. Objective: Evaluation of Sig1R, SOD1, and SOD2 expression in different concentrations of oxygen (1%, 10%, 21%) in colon adenocarcinoma cell lines. Materials and methods: SW480 (primary adenocarcinoma) and SW620 (metastatic) cell lines were cultured in standard conditions in Dulbecco’s modified Eagle’s medium for 5 days, and next cultured in Hypoxic Chamber in 1% O2, 10% O2, 21% O2. Number of living cells was determined by trypan blue assay. Level of mRNA for Sig1R, SOD1, and SOD2 was determined by standard PCR method. Statistical analysis was conducted using Statistica 10.1 software. Results: We observed significant changes in expression of Sig1R, SOD1, SOD2 due to different oxygen concentrations. ANOVA analysis revealed significant interactions between studied parameters mainly in hypoxia conditions in SW480 cells and between Sig1R and SOD2 in SW620 cells. It also showed that changes in expression of studied proteins depend significantly on type of the cell line. Conclusion: Changes of Sig1R and SOD2 expression point to mitochondria as main organelle responsible for survival of tumor cells exposed to hypoxia or oxidative stress. Studied proteins are involved in intracellular response to stress related with different concentrations of oxygen.


  • Lactate Formation in Primary and Metastatic Colon Cancer Cells at Hypoxia and Normoxia

    by Wojciech Graboń, Dagmara Otto‐Ślusarczyk, Alicja Chrzanowska, Magdalena Mielczarek‐Puta, Ilona Joniec‐Maciejak, Krzysztof Słabik, Anna Barańczyk‐Kuźma

    High glucose consumption and lactate synthesis in aerobic glycolysis are a hallmark of cancer cells. They can form lactate also in glutaminolysis, but it is not clear how oxygen availability affects this process. We studied lactate synthesis at various oxygen levels in human primary (SW480) and metastatic (SW620) colon cancer cells cultured with L‐Ser and/or L‐Asp. Glucose and lactate levels were determined colorimetrically, amino acids by HPLC, expression of AST1‐mRNA and AST2‐mRNA by RT‐PCR.In both lines glucose consumption and lactate synthesis were higher at 10% than at 1% oxygen, and lactate/glucose ratio was increased above 2.0 by L‐Asp.AST1‐mRNA expression was independent on oxygen and cell line, but AST2‐mRNA was lower at hypoxia in SW480.We conclude that, in both cell lines at 1% hypoxia, lactate is formed mainly from glucose but at 10% normoxia also from L‐Asp. At 10% normoxia, lactate synthesis is more pronounced in primary than metastatic colon cancer cells.